Infection Control Today Magazine - healthcare-acquired infections (HAIs), hospital infections, infection prevention and control, healthcare epidemiology, aseptic technique, environmental hygiene, hand hygiene, disinfection and sterilization, outbreak investigation, surveillance

FEATURES

CDC Protocols Cut Dialysis Infections

The Centers for Disease Control and Prevention (CDC) has released results of its Dialysis Bloodstream Infection Prevention Collaborative showing a 32 ...read more

Antimicrobial Resistance

The resistance of bacteria to antibiotics and similar drugs—called antimicrobials—is considered a major public health threat by the Food and Drug ...read more

Clostridium difficile

This report explores the essentials of Clostridium difficile, one of the most problematic pathogens facing healthcare institutions today. It provides ...read more

Clostridium difficile

Infection Control Today reports on the prevalence of Clostridium difficile, including hospitals' efforts to prevent and control this ...read more

Latest Headlines

3M-Sponsored Video Updates Healthcare Professionals On New CDC Guidelines for Hand Hygiene

ST. PAUL, Minn. -- 3M Health Care has sponsored a new video to make it easier for healthcare professionals to update their procedures in light of the new hand hygiene guidelines issued recently by the Centers for Disease Control and Prevention (CDC). The video, "Hand ...More
October 14, 2003
Posted in News, Environmental Hygiene, Hand Hygiene
Novel Antifungal Agent Demonstrates Activity Against Coccidioidomycosis, a Potentially Deadly Fungal Disease

KENILWORTH, N.J. -- Schering-Plough Corporation today reported results from a case series evaluating the efficacy and safety of NOXAFIL (posaconazole oral suspension) for the treatment of coccidioidomycosis, a potentially deadly fungal disease, after standard antifungal ...More
October 14, 2003
Posted in News
Early Virologic Response (EVR) to PEG-INTRON Individualized Weight-Based Therapy For Hepatitis C Evaluated In Study Published in Hepatology

KENILWORTH, N.J. -- Early virologic response (EVR) in patients with chronic hepatitis C following 12 weeks of individualized, weight-based dosing of PEG-INTRON (peginterferon alfa-2b) Powder for Injection in combination with REBETOL (ribavirin, USP) capsules demonstrates a ...More
October 14, 2003
Posted in News
Nabi Biopharmaceuticals Accelerates Commercialization Plans for StaphVAX

ROCKVILLE, Md. -- Nabi Biopharmaceuticals today announced it is significantly accelerating its timeline for licensing and commercializing its lead development product, StaphVAX (S. aureus polysaccharide conjugate vaccine). StaphVAX is an investigational vaccine being ...More
October 14, 2003
Posted in News
AORN Celebrates Perioperative Nurse Week Nov. 9-15, 2003

DENVER -- When patients are faced with the prospect of surgery, it's important for them to know they can rely on the skills, knowledge and expertise of perioperative registered nurses. AORN, the Association of periOperative Registered Nurses, is proud to honor perioperative ...More
October 14, 2003
Posted in News
VHA Health Foundation Receives Grant to Develop Quality Care Measures for Sepsis Care

IRVING, Texas -- The VHA Health Foundation is undertaking an initiative to develop, test and disseminate quality measures for the treatment of patients with severe sepsis, which strikes an estimated 750,000 people in the U.S. annually, resulting in 215,000 deaths. The VHA ...More
October 13, 2003
Posted in News
Texas Joins CDC's Emerging Infections Program Network

WASHINGTON -- Texas has become the 11th Emerging Infections Program (EIP) site in the United States. The Centers for Disease Control and Prevention (CDC) established EIP sites in 1995 as part of the agency's strategy to address the ongoing threat of emerging infectious ...More
October 13, 2003
Posted in News
Researchers Neutralize SARS Virus in Lab Tests

WORCESTER, Mass. and PRINCETON, N.J. -- Presenting last Saturday at the annual meeting of the Infectious Disease Society of America, a team of scientists from the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) in Jamaica ...More
October 13, 2003
Posted in News, PPE & Standard Precautions
FDA Warns Consumers Not to Use Decorative Contact Lenses Without Proper Professional Involvement

WASHINGTON, D.C. -- With the Halloween season approaching, the Food and Drug Administration (FDA) is warning consumers about serious risks of using decorative contact lenses distributed without appropriate involvement from an eye care professional. These decorative lenses ...More
October 13, 2003
Posted in News, PPE & Standard Precautions
FDA Grants Tanox's Anti-CD4 Drug Fast Track Status for the Treatment of HIV-1

HOUSTON, Texas -- Tanox, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track status to TNX-355 for the treatment of patients with human immunodeficiency virus 1 (HIV-1) infection who have failed or are failing antiretroviral therapy. ...More
October 13, 2003
Posted in News